The MIRI was very well represented at the annual Perinatal Research Society Annual Meeting Utah from September 29-October 1, in the beautiful setting of Park City.
A new, three-year NIH grant will expand Dr. Elizabeth Yen's research and initial pilot study findings about the effects of prenatal opioid exposure in an infant's first year of life.
Targeted genome sequencing found to deliver routine results more quickly and at a lower cost; lack of standardization in analytic techniques remains a barrier to diagnosis and medical care for genetic disorders in the first year of life.
Tufts Clinical and Translational Science Institute (CTSI) has received a $78.4 million Clinical and Translational Science Award from the NIH, the fourth consecutive grant since its founding in 2008.
Tufts Medicine announced today that Perrie O'Tierney-Ginn, PhD, has been named the permanent Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center. She had served as the Interim Executive Director of MIRI since September 2021.
A comprehensive review study has found that Medicaid and commercial insurance coverage policies for Biogen Alzheimer’s disease drug, Aduhelm, showed large inconsistencies based on plan and geography.
Tufts MC's Predictive Analytics and Comparative Effectiveness (PACE) Center the Recipient of National Institute of Neurological Disorders and Stroke (NINDS) Grant.
In order to further strengthen the connection between the MIRI and investigators involved in complementary work across Tufts Medicine and Tufts University, MIRI created the role of "Associate PI."